Research ArticleClinical Studies
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA
Anticancer Research April 2022, 42 (4) 2033-2043; DOI: https://doi.org/10.21873/anticanres.15684
YUICHI TACHIKAWA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
KAZUSHIGE KAWAI
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
KOSUKE OZAKI
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
HIROAKI NOZAWA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
KAZUHITO SASAKI
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
KOJI MURONO
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
SHIGENOBU EMOTO
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
JUNKO KISHIKAWA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
YUICHIRO YOKOYAMA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
SHINYA ABE
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
YUZO NAGAI
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
HIROYUKI ANZAI
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
HIROFUMI SONODA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
SOICHIRO ISHIHARA
Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA, SOICHIRO ISHIHARA
Anticancer Research Apr 2022, 42 (4) 2033-2043; DOI: 10.21873/anticanres.15684
CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA, SOICHIRO ISHIHARA
Anticancer Research Apr 2022, 42 (4) 2033-2043; DOI: 10.21873/anticanres.15684
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.